![Ben Ferrari](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ben Ferrari
Nessuna posizione attualmente
Profilo
Ben Ferrari held positions as Director at Surrey, Inc., Research Director at the University of St. Andrews, Managing Director at Imprimatur Capital Ltd., Non-Executive Director at Evgen Ltd., Principal at the University of Surrey, and Principal at Royal Holloway University of London.
Precedenti posizioni note di Ben Ferrari
Società | Posizione | Fine |
---|---|---|
Imprimatur Capital Ltd.
![]() Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Amministratore Delegato | 01/01/2012 |
University of Surrey | Corporate Officer/Principal | - |
University of St. Andrews | Direttore Tecnico/Scientifico/R&S | - |
Royal Holloway University of London | Corporate Officer/Principal | - |
Surrey, Inc. | Direttore/Membro del Consiglio | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
Surrey, Inc. | Consumer Non-Durables |
Imprimatur Capital Ltd.
![]() Imprimatur Capital Ltd. Investment ManagersFinance Imprimatur Capital Ltd. (Imprimatur Capital) is a venture capital firm founded in 2003 by Ian Watson. The firm is headquartered in London with additional office in Singapore. | Finance |
Evgen Ltd.
![]() Evgen Ltd. Medical/Nursing ServicesHealth Services Evgen Ltd. develops novel glucosinolate based products for the prevention and treatment of human disease. It engages in the clinical stage drug development that lead programmes are in breast cancer and subarachnoid haemorrhage, a type of stroke. Its activities also include carrying out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. The firm holds proprietary technology that enables sulforaphane to be synthesized and then subsequently stabilized for pharmaceutical application. The company was founded by Dr. Stephen Franklin on October 18, 2007 and is headquartered in Liverpool, the United Kingdom. | Health Services |
- Borsa valori
- Insiders
- Ben Ferrari